ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 1383

$795K Total Retail Price of All Prescriptions

Rank: 117 out of 1383

526 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 526 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 526 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 12,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 757 602 1 2
LISINOPRIL 715 526 2 3
LEVOTHYROXINE SODIUM 622 503 3 4
OMEPRAZOLE 590 449 4 5
METOPROLOL TARTRATE 477 354 5 9
FUROSEMIDE 476 339 6 7
POTASSIUM CHLORIDE 423 343 7 12
AMLODIPINE BESYLATE 325 258 8 6
HYDROCHLOROTHIAZIDE 313 280 9 10
GABAPENTIN 304 228 10 11
HYDROCODONE-ACETAMINOPHEN 285 195 S3 11 1
NEXIUM 280 197 12 26
WARFARIN SODIUM 271 198 13 13
CRESTOR 268 214 14 34
GLIMEPIRIDE 266 223 15 31
METFORMIN HCL 242 209 16 8
GLYBURIDE 237 167 R 17 46
RANITIDINE HCL 215 127 18 19
CEFUROXIME 206 131 19 164
LANTUS 203 143 20 50
ATENOLOL 198 161 21 16
CITALOPRAM HBR 195 116 22 15
SERTRALINE HCL 187 149 23 21
ATORVASTATIN CALCIUM 187 127 23 18
FLUTICASONE PROPIONATE 183 114 25 39
PRAVASTATIN SODIUM 181 156 26 14
DIOVAN 171 162 27 58
ALLOPURINOL 170 118 28 33
COMBIVENT 169 128 29 116
METFORMIN HCL ER 169 95 29 47
PREDNISONE 159 118 31 40
TAMSULOSIN HCL 154 117 32 30
MELOXICAM 144 93 33 20
INSULIN SYRINGE 141 109 34 83
TRAZODONE HCL 138 98 35 36
AMITRIPTYLINE HCL 128 81 R 36 57
CLOPIDOGREL 120 90 37 28
PLAVIX 115 100 38 43
CYCLOBENZAPRINE HCL 110 52 R 39 69
SPIRIVA 109 51 40 45
TIZANIDINE HCL 104 78 41 104
PRAMIPEXOLE DIHYDROCHLORIDE 104 70 41 160
HYDROXYZINE HCL 101 56 R 43 151
FLUOXETINE HCL 100 66 44 52
AZITHROMYCIN 98 52 45 41
FAMOTIDINE 86 60 46 61
PAROXETINE HCL 83 51 47 55
PREMARIN 83 66 R 47 123
SINGLE USE SWAB 81 54 49 296
NYSTATIN 77 47 50 132
CARVEDILOL 76 62 51 24
COLCRYS 75 56 52 214
ZOLPIDEM TARTRATE 72 41 53 17
TERAZOSIN HCL 71 60 54 111
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 43 55 89
MUPIROCIN 69 48 56 189
METHYLPREDNISOLONE 67 35 57 133
ALENDRONATE SODIUM 66 39 58 37
SYNTHROID 65 47 59 73
PROAIR HFA 65 51 59 42
CIPROFLOXACIN HCL 64 45 61 54
PANTOPRAZOLE SODIUM 63 47 62 32
DOXYCYCLINE HYCLATE 63 43 62 94
IBUPROFEN 61 21 64 91
DIOVAN HCT 60 39 65 103
POLYETHYLENE GLYCOL 3350 59 23 66 64
GLIPIZIDE 59 47 66 98
LOSARTAN POTASSIUM 59 28 66 23
LIPITOR 57 42 69 158
LOSARTAN-HYDROCHLOROTHIAZIDE 56 39 70 60
HYDROXYZINE PAMOATE 55 51 R 71 283
ISOSORBIDE MONONITRATE ER 53 48 72 66
BACLOFEN 53 0 72 118
LEVEMIR 53 46 72 145
DILTIAZEM 24HR CD 53 37 72 95
NAPROXEN SODIUM 52 47 76 274
DEXILANT 52 15 76 140
METOPROLOL SUCCINATE 51 37 78 29
ENALAPRIL MALEATE 51 45 78 75
OXYCODONE-ACETAMINOPHEN 50 0 S2 80 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.